Isotypes of rheumatoid factors in rheumatoid arthritis and chronic liver diseases

References

• Youinou PY, Morrow JW, Lettin AWF, Lydyard OM, Roitt IM. Specificity of plasma cells in the rheumatoid synovium. I: Immuno-globulin class of anti-globulin producing cells. Scand J Immunol 1984;20:307–15.
   Google Scholar
• Sliwinskii A, Zvaifler N. In vitro synthesis of IgG by rheumatoid synovium. J Clin Lab Med 1970;76:304–10.
   Google Scholar
• Shmerling RH, Dethane° TL. The rheumatoid factor: an analysis of clinical utility. Am J Med 1991;91:528–34.
   PubMed Web of Science ®Google Scholar
• Van Schaardenburg D, Laggay AM, Otten HG, Bleedveld FC. The relation between class-specific serum rheumatoid factors and age in general population. Br J Ftheumatol 1993;32:546–9.
   PubMedGoogle Scholar
• Teitsson I, Withrington RH, Seifert MH, Valdimarsson H. Pro-spective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor. Ann Rheum Dis 1984;43:673–8.
   PubMed Web of Science ®Google Scholar
• Jonsson T, Thorsteinsson J, Kobeinsson A, Honasdottir E, Sigfusson N, Valdimarsson H. Population study of the importance of rheumatoid factor isotypes in adults. Ann Rheum Dis 1992; 51:863–8.
   PubMed Web of Science ®Google Scholar
• Jonsson T, Valdimarsson H. Is measurement of rheumatoid factor isotypes clinically useful? Ann Rheum Dis 1993;52:161–4.
   PubMed Web of Science ®Google Scholar
• Jonsson Y, Valdimarsson H. Clinical significance of rheumatoid factor isotypes in seropositive arthritis. Ftheumatol hit 1992;12: 111–3.
   PubMed Web of Science ®Google Scholar
• Houssien DA, Jonsson T, Davies E, Scott DL. Clinical significance of IgA rheumatoid factor subclasses in rheumatoid arthritis. J Ftheumatol 1997;24:2119–22.
   Google Scholar
• Mageed RA, Kirwan JR, Thompson PW, McCarthy DA, Holborow EJ. Characterization of the size and composition of circulating immune complexes in patients with rheumatoid arthri-tis. Ann Rheum Dis 1991;50:231–6.
   Google Scholar
• Houssien DA, Jonsson T, Davies W, Scott L. Rheumatoid factor isotypes, disease activity and the outcome of rheumatoid arthritis. Scand J Ftheumatol 1998;27:46–53.
   PubMed Web of Science ®Google Scholar
• Scott DG, Bacon PA, Allen C, Elson CJ, Wallington T. IgG rheumatiod factor, complement and immune complexes in rheu-matoid synovitis and vasculitis: comparative and serial studies dur-ing cytotoxic therapy. Clin Exp Immunol 1981;43:54–63.
   Google Scholar
• Silvestris F, Goodwin JS, Williams RC Jr. 1gM, IgA and IgG rheu-matoid factors in patients with rheumatoid arthritis and normal donors. Clin Ftheumatol 1985;4: 392–8.
   Google Scholar
• Jonsson T, Steinsson K, Jonsson H, Geirsson AJ, Thorsteinsson J, Valdimarson H. Combined elevation of IgM and IgA rheumatoid factor has high diagnostic specificity for rheumatoid arthritis. Ftheumat Int 1998;18:119–22.
   PubMedGoogle Scholar
• Pai S, Pai L, Birkenfeldt R. Correlation of serum IgA rheumatoid factor levels with disease severity in rheumatoid arthritis. Scand J Ftheumatol 1998;27:252–6.
   Google Scholar
• Jonsson T, Arinbjarnarson S, Thorsteinsson J, Steinsson K, Geirsson AJ, Jonsson H, Valdimarsson H. Raised IgA rheuma-toid factor (RF) but not IgM RF or IgG RF is associated with extra-articular manifestations in rheumatoid arthritis. Scand J Ftheumatol 1995;24:372–5.
   Google Scholar
• Hajeer AH, Lazarus M, Turner D, Mageed RA, Vancovsky J, Sinnott P, et al. IL-10 gene promoter polymorphisms in rheuma-toid arthritis. Scand J Ftheumatol 1998;27:142–5.
   PubMed Web of Science ®Google Scholar
• Takowski A, Westberg G. Rheumatoid factor isotypes and renal disease in systemic lupus erythematosus. Scand J Ftheumatol 1987;16:309–12.
   PubMedGoogle Scholar
• Feldman D, Feldman D, Ginzler E, Kaplan D. Rheumatoid factor in patients with systemic lupus erythematosus. J Ftheumatol 1989;16:618–22.
   Google Scholar
• Wang C-H, Flehmig B, Tschen S-Y. Hepatitis C virus, rheumatoid factors, and disease progression. Lancet 1998;351:294.
   Google Scholar
• Stone R, Coppoccck JS, Dawes PT, Bacon PA, Scott DL. Clinical value of ELISA assays for IgM and IgG rheumatoid factors. J Clin Pathol 1987;40:107–11.
   Google Scholar
• Nordfang O, Hoier-Madsen M, Halberg P, Liebenkind J. A new radioimmunoassay for IgIVI and IgG rheumatoid factors, based on a double antibody method. J Immunol Methods 1986;47: 87–97.
   Google Scholar
• Dabadghao S, Misra R, Naveed M, Aggarwal A. IgM rheumatoid factor estimation by ELISA in seronegative rheumatoid arthritis before and after IgM fractionation:does seronegative RA exist? Ftheumatol Int 1996;15:189–93.
   PubMedGoogle Scholar
• Aggarwal A, Dabadghao S, Naik S, Mirsa R. Serum IgM rheumatiod factor by enzyme-linked immunosorbent assay (ELISA) delinates a subset of patients with deforming joint disease in seronegative juvenile rheumatoid arthritis. Rheum Int 1994;14:135–8.
   PubMedGoogle Scholar
• Dighiero G. Natural autoantibodies, tolerance, and autoimmunity. Ann N Y Acad Sci 1997;815:182–92.
   PubMedGoogle Scholar
• Nakamura M, Burastero SE, Notokins AL, Casali P. Human monoclonal rheumatoid factor-like antibodies from CD5 (Leu-1)+ B cells are polyreactive. J Immunol 1988;140:4180–6.
   PubMed Web of Science ®Google Scholar
• Aho K, Heliovaara M, Knekt P, Reunanen A, Aromaa A, Leino A, et al. Serum immunoglobulins and the risk of rheumatoid arthri-tis. Ann Rheum Dis 1997;56:351–6.
   PubMedGoogle Scholar
• Louzir H, Ternynck T, Gorgi Y, Tahar S, Ayed K, Avrameas S. Autoantibodies and circulating immune complexes in sera from patients with hepatitis B virus-related chronic liver disease. Clin Immunol Immunopathol 1992;62:160–7.
   PubMedGoogle Scholar
• Pawlotsky J-M, Yahia MB, Andre C, Voisin M-C, Intrator L, Roudot-Thoraval F, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994;19:841–8.
   Google Scholar
• Durand JM, Lefevre P, Harle JR, Boucrat J, Vitvitski L, Soubeyrand J. Cutaneous vasculitis and cryoglobulinemia type 2 associated with hepatitis C virus infection. Lancet 1991;337: 499–500.
   PubMedGoogle Scholar
• Yoshizawa H, Nojiri N, Takahashi K. Measurement of anti-GOR antibodies in prevention of post-transfusion non-A, non-B hepati-tis. Lancet 1991;337:47–8.
   Google Scholar
• Lunel F, Abuaf N, Frangeul L, Grippon P, Perrin M, Le Coz Y, et al. Liver/kidney microsome antibody type 1 and hepatitis C infec-tion. Hepatology 1992;16: 630–6.
   Google Scholar
• Imai H, Ochs RL, Kiyosawa K, Furuta S, Nakamura RM, Tan EM. Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies. Am J Pathol 1992;140:859–70.
   PubMed Web of Science ®Google Scholar
• Lovy ML, Starkebaum G, Uberoi S. Hepatitis C infection present-ing with rheumatic manifestations: a mimic of rheumatoid arthritis. J Ftheumatol 1996;23:979–83.
   Google Scholar